Roche Holding AG said a multiple sclerosis drug showed it could work for most forms of the disease in two late-stage trials, ...

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...

Aging and shifting hormone levels influence how MS changes over time, and the overlap of these factors during midlife can ...

After her MS diagnosis, Becky was worried her kids would have to care for her, but a stem cell transplant has changed the ...

Columnist Ben Hofmeister sings the praises of his wife and caregiver, who knows that living with MS is like speaking a foreign language.

In a new book, Ashley Schneider details her journey of running 125 consecutive marathons across America to raise awareness ...

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition in which the body's ...

Early intervention and effective therapies are transforming multiple sclerosis management, enhancing patient outcomes, and delaying disability progression.

After 30 years of living with Multiple Sclerosis (MS), country music star Clay Walker shared that the disease has recently ...

Roche has reported wins for its BTK inhibitor fenebrutinib in a pair of phase 3 studies across two multiple sclerosis (MS) populations. One victory was based on the finding that the candidate was ...

The singer says he's had an unexpectedly long recovery after undergoing surgery to treat his MS symptoms in March 2025.